Clinical trial
Neutrophil Gelatinase-associated Disease: a Potential Biomarker of the Severity of Coronary Artery Disease
NCT00749281 is registered in ClinicalTrials.gov with Cardiovascular Research Society, Greece as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neutrophil Gelatinase-associated Disease: a Potential Biomarker of the Severity of Coronary Artery Disease
- Lead sponsor
- Cardiovascular Research Society, Greece
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- September 30, 2009
- Enrollment
- 73 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.